SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-065532
Filing Date
2021-11-18
Accepted
2021-11-18 17:08:18
Documents
2
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1510
2 EX-24 DOCUMENT attachment1.htm EX-24 3409
  Complete submission text file 0001209191-21-065532.txt   6349
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 201 ROUTE 17 NORTH RUTHERFORD NJ 07070
Business Address
CZEREPAK ELIZABETH (Reporting) CIK: 0001263500 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36150 | Film No.: 211425273